kabutan

Kringle Pharma, Oct-Jun (Cumulative 3Q) Net Income Loss Widens, Apr-Jun Net Income Loss Widens

Fri Aug 8, 2025 3:40 pm JST Earnings

4884 Kringle Pharma,Inc. 【J-GAAP】

Earnings Report

Kringle Pharma,Inc. <4884> [TSE Growth] announced its financial results after the market closed on August 8th (15:40). The net loss (non-consolidated) for the cumulative third quarter of the fiscal year ending September 2025 (October 2024 to June 2025) expanded to a loss of 739 million yen (compared to a loss of 518 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the July to September period (4Q) is expected to further decrease loss of 207 million yen (compared to a loss of 238 million yen in the same period last year).

In the most recent three-month period, from April to June (3Q), the net loss expanded to a loss of 227 million yen (compared to a loss of 152 million yen in the same period last year). The operating profit/loss margin drastically worsened from -1183.3% in the same period last year to -1261.1%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Oct - Jun, 2022 51 -620 -577 -578 -107.5 Aug 14, 2023 J-GAAP
Oct - Jun, 2023 61 -579 -517 -518 -82.8 Aug 9, 2024 J-GAAP
Oct - Jun, 2024 53 -738 -738 -739 -108.4 Aug 8, 2025 J-GAAP
YoY -13.1% -27.5% -42.7% -42.7% -30.9%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 37 -451 -389 -390 -61.0 0 Nov 13, 2024 J-GAAP
Apr - Sep, 2025 Guidance 36 -428 -434 -434 -62.0 0 Jul 16, 2025 J-GAAP
YoY -2.7% +5.1% -11.6% -11.3% -1.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2023 69 -888 -852 -854 -158.5 0 Nov 13, 2023 J-GAAP
Sep, 2024 80 -817 -754 -756 -118.2 0 Nov 13, 2024 J-GAAP
Sep, 2025 Guidance 71 -939 -945 -946 -135.2 0 Jul 16, 2025 J-GAAP
YoY -11.3% -14.9% -25.3% -25.1% -14.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 18 -213 -152 -152 -24.3 -1,183.3 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 19 -238 -237 -238 -37.2 -1,252.6 Nov 13, 2024 J-GAAP
Oct - Dec, 2024 18 -212 -212 -212 -31.2 -1,177.8 Feb 7, 2025 J-GAAP
Jan - Mar, 2025 17 -299 -299 -300 -44.0 -1,758.8 May 12, 2025 J-GAAP
Apr - Jun, 2025 18 -227 -227 -227 -33.3 -1,261.1 Aug 8, 2025 J-GAAP
YoY 0.0% -6.6% -49.3% -49.3% -37.1%

Related Articles